What did @elevatemd actually say?
The creator cited a "retrospective cohort analysis conducted by the Mayo Clinic" claiming that women taking HRT alongside a GLP-1 medication lost "35% more weight" than women on a GLP-1 alone. They framed this as evidence that hormones are a missing piece in metabolic treatment for perimenopausal and menopausal women, and closed with a call to get hormone levels checked if metabolism feels off.
That's a specific, quantified claim tied to a named institution. Specific claims are checkable, which is where things get complicated.
Does the science back this up?
Partially, but the 35% figure needs more scrutiny than this video gives it. A 2024 retrospective study from the Mayo Clinic (Faubion et al., 2024, Menopause) did examine GLP-1 use with and without MHT in midlife women and found meaningfully greater weight loss in the combination group. The direction of the finding is real. But retrospective cohort data has significant limitations: it cannot establish causation, the groups were not randomized, and confounders like baseline health, diet, and activity were not fully controlled.
Separately, the broader biology is reasonably well supported. Estrogen deficiency during menopause is associated with increased visceral adiposity and reduced insulin sensitivity (Davis et al., 2012, Nature Reviews Endocrinology). GLP-1 receptor agonists work partly through appetite suppression and slowed gastric emptying. Restoring estrogen may improve the hormonal environment in which these drugs operate. The mechanistic story is plausible. One retrospective study is not proof.
What did they get wrong (or right)?
Credit where it's due: the general claim that hormonal changes in perimenopause affect metabolic function is accurate and often underappreciated in clinical settings. Pointing women toward hormone evaluation is not bad advice on its face.
What they got wrong, or at least oversimplified: presenting "35% more weight loss" as a settled fact rather than a preliminary signal from one non-randomized study. Retrospective cohorts tell you what happened in a specific patient population at one institution. They do not tell you what will happen to you. The creator said this is "actually insane" and framed it as a definitive answer rather than emerging evidence worth discussing with a provider.
There's also a category issue. This video is filed under TRT, which covers testosterone therapy. The study and the discussion here are about estrogen-based hormone therapy, not testosterone. Those are different interventions with different evidence bases and different risk profiles. Conflating them, even implicitly through categorization, creates confusion.
- The Mayo Clinic study result is real but preliminary
- Retropsective data cannot confirm cause and effect
- Estrogen's role in metabolic function has solid mechanistic support
- The TRT category label does not match the content
What should you actually know?
If you're a woman in your 40s or 50s finding that weight management has become harder despite no major lifestyle changes, hormonal shifts are a legitimate contributor worth evaluating. Estrogen decline affects body composition, insulin sensitivity, and fat distribution. That part is not hype.
GLP-1 receptor agonists are effective tools for weight management and metabolic dysfunction, with strong trial data behind them (Wilding et al., 2021, NEJM). Whether adding hormone therapy meaningfully amplifies those results in your specific case is a clinical question, not one a TikTok video can answer. The Mayo Clinic finding is worth knowing about and worth raising with your provider. It is not worth treating as a prescription.
Hormone therapy also carries individual risk considerations, including cardiovascular history and cancer risk factors, that require a full clinical evaluation. The "get your hormone levels checked" advice is reasonable. The implied conclusion that HRT plus a GLP-1 is a straightforward upgrade for everyone is not.